Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 1,887 $ 3,348
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 509 500
Amortization of discount and debt issuance costs 20 22
Loss on modification or extinguishment of debt 3 6
Total gains on derivative instruments, net (316) (1,867)
Net cash provided by settlement of derivative instruments 23 6
Other 13 16
Changes in operating assets and liabilities:    
Trade and other receivables 134 340
Trade receivables—affiliate 79 384
Inventory 6 30
Accounts payable and accrued liabilities (259) (662)
Accrued liabilities—related party 0 (2)
Total deferred revenue 47 59
Other, net (41) 14
Other, net—affiliate (13) (1)
Net cash provided by operating activities 2,092 2,193
Cash flows from investing activities    
Property, plant and equipment, net (105) (170)
Other (7) (6)
Net cash used in investing activities (112) (176)
Cash flows from financing activities    
Proceeds from issuances of debt 1,228 1,397
Redemptions and repayments of debt (1,680) (1,650)
Debt issuance and other financing costs (15) (32)
Distributions (1,729) (2,190)
Other (4) (4)
Net cash used in financing activities (2,200) (2,479)
Net decrease in cash, cash equivalents and restricted cash and cash equivalents (220) (462)
Cash, Cash Equivalents—beginning of period 631 996
Cash, Cash Equivalents—end of period $ 411 $ 534